ATE213644T1 - Kombinationstherapie für die behandlung von arthritis erkrankungen - Google Patents

Kombinationstherapie für die behandlung von arthritis erkrankungen

Info

Publication number
ATE213644T1
ATE213644T1 AT97942106T AT97942106T ATE213644T1 AT E213644 T1 ATE213644 T1 AT E213644T1 AT 97942106 T AT97942106 T AT 97942106T AT 97942106 T AT97942106 T AT 97942106T AT E213644 T1 ATE213644 T1 AT E213644T1
Authority
AT
Austria
Prior art keywords
combination therapy
treatment
arthritis diseases
diseases
arthritis
Prior art date
Application number
AT97942106T
Other languages
English (en)
Inventor
Lars Michael Wood
David Olum Laber
Annette Wright
Original Assignee
British Biotech Pharm
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by British Biotech Pharm filed Critical British Biotech Pharm
Application granted granted Critical
Publication of ATE213644T1 publication Critical patent/ATE213644T1/de

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • A61K38/04Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/12Cyclic peptides, e.g. bacitracins; Polymyxins; Gramicidins S, C; Tyrocidins A, B or C
    • A61K38/13Cyclosporins
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Immunology (AREA)
  • Rheumatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Pain & Pain Management (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Iron Core Of Rotating Electric Machines (AREA)
AT97942106T 1996-09-20 1997-09-18 Kombinationstherapie für die behandlung von arthritis erkrankungen ATE213644T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB9619631.6A GB9619631D0 (en) 1996-09-20 1996-09-20 Combination therapy
PCT/GB1997/002604 WO1998011908A1 (en) 1996-09-20 1997-09-18 Combination therapy for treatment of arthritic diseases

Publications (1)

Publication Number Publication Date
ATE213644T1 true ATE213644T1 (de) 2002-03-15

Family

ID=10800216

Family Applications (1)

Application Number Title Priority Date Filing Date
AT97942106T ATE213644T1 (de) 1996-09-20 1997-09-18 Kombinationstherapie für die behandlung von arthritis erkrankungen

Country Status (7)

Country Link
EP (1) EP0936918B1 (de)
JP (1) JP2001500873A (de)
AT (1) ATE213644T1 (de)
AU (1) AU4390597A (de)
DE (1) DE69710752D1 (de)
GB (1) GB9619631D0 (de)
WO (1) WO1998011908A1 (de)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AUPP584198A0 (en) * 1998-09-14 1998-10-08 Fujisawa Pharmaceutical Co., Ltd. New use
PT2762140T (pt) 2001-02-19 2017-07-04 Novartis Ag Resumo
TW200902047A (en) * 2003-02-14 2009-01-16 Combinatorx Inc Methods and reagents for the treatment of diseases and disorders associated with increased levels of proinflammatory cytokines

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2290543B (en) * 1993-03-16 1996-05-22 British Biotech Pharm Hydroxamic acid derivatives as metalloproteinase inhibitors

Also Published As

Publication number Publication date
WO1998011908A1 (en) 1998-03-26
DE69710752D1 (de) 2002-04-04
AU4390597A (en) 1998-04-14
JP2001500873A (ja) 2001-01-23
EP0936918B1 (de) 2002-02-27
GB9619631D0 (en) 1996-11-06
EP0936918A1 (de) 1999-08-25

Similar Documents

Publication Publication Date Title
DE69718731D1 (de) Kombinationstherapie für die Behandlung von Psychosen
PT971713E (pt) Utilizacao de inibidores da colinesterase para tratamento de desordens da atencao
DE69905938D1 (de) Kombination von duloxetin mit nichtsteroid-entzündungshemmern für die behandlung von schmerz
DE59608738D1 (de) Verwendung von epinastin für die behandlung von schmerzen
ATE301457T1 (de) Mittel, enthaltend einen cyclooxygenase-2 inhibitor und einen 5-lipoxygenase inhibitor
DE69826695D1 (de) Arylharnstoffderivate zur behandlung von inflammatorischen oder immunomodulatorischen erkrankungen
TR199801151T2 (xx) Trombin inhibit�r� �n ila�lar.
NZ335981A (en) Ketobenzamides as calpain inhibitors
ATE315390T1 (de) Zyklische polyamine zur behandlung der thrombozytopenie
TR200200673T2 (tr) Rinovirüs enfeksiyonlarında csaıd'lerin kullanılması
ATE214272T1 (de) Topische verwendung von kappa- opioidrezeptoragonisten zur behandlung von augenschmerz
EP0758021A3 (de) Verfahren zur Bestimmung der therapeutischen Wirkung von Metalloproteinase-Verbindungen, neue Inhibitor-Verbindungen und deren therapeutische Verwendung
DE59801385D1 (de) Durchlaufanlage für die behandlung von werkstücken
DE69423533D1 (de) Zubereitungen zur Behandlung von Impotenz, die ein Alpha-1 inhibitor und ein Alpha-2 inhibitor enthalten
ATE273995T1 (de) Spezifische inhibitoren der pankreatischen lipase und deren anwendungen
ATE213644T1 (de) Kombinationstherapie für die behandlung von arthritis erkrankungen
ATE338566T1 (de) Aldosteronantagonist und cyclooxygenase-2 hemmer- kombinationstherapie zur verhinderung oder behandlung von entzündungsverwandten kardiovaskulären krankheiten
ID27052A (id) Pengobatan arthritis dan keadaan-keadaan lain yang sekupa
DE69930844D1 (de) Inhibitoren von mycobakterien
DE59813914D1 (de) Mittel zur behandlung und/oder prophylaxe von mikrozirkulationsstörungen
ATE360425T1 (de) Verwendung von quetiapin für die behandlung von kokain-abhängigkeit
ATE365718T1 (de) Substituierte 11-phenyl-dibenzazepin-verbindungen,die nützlich sind zur behandlung oder vorbeugung von durch abnormale zellproliferation gekennzeichneten krankheiten
NO984198L (no) FremgangsmÕte for behandling av aggresjon
FR2769013B1 (fr) Traitement des boues de curage
DE4393916D2 (de) Aufbereitungsanlage für die Behandlung von Abwässern

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties